Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 34.09M $6.77B March 31, 2015
T. Rowe Price Associates 20.13M $4.00B March 31, 2015
Pershing Square Capital Management 19.47M $3.87B March 31, 2015
ValueAct Holdings 18.92M $2.48B Sept. 30, 2014
Barclays 15.24M $3.02B March 31, 2015
FMR 12.21M $2.71B June 30, 2015
BANK OF MONTREAL /CAN/ 7.65M $1.70B June 30, 2015
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
JPMORGAN CHASE & CO 6.21M $1.38B June 30, 2015
Greystone Managed Investment 5.83M $311.84M March 31, 2012
Brahman Capital 5.67M $304.61M March 31, 2012
Brave Warrior Advisors 5.59M $737.27M March 31, 2014
Toronto-Dominion Bank 5.48M $718.34M Sept. 30, 2014
Blue Ridge Capital 5.45M $254.46M Dec. 31, 2011
GOLDMAN SACHS 5.34M $764.42M Dec. 31, 2014
Lone Pine Capital 5.31M $1.18B June 30, 2015
Loomis, Sayles and 4.69M $550.74M Dec. 31, 2013
Name Goodman & Company, Investment Counsel 4.62M $207.08M June 30, 2012
VIKING GLOBAL INVESTORS 4.62M $1.03B June 30, 2015
Caisse de depot et placement du Quebec 4.57M $599.53M Sept. 30, 2014
Janus Capital Management 4.54M $391.19M June 30, 2013
CIBC World Markets 4.51M $896.19M March 31, 2015

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Sept. 30, 2012 4.86M $255.76M
HARRIS FINANCIAL Sept. 30, 2011 5.69M $211.13M
Royal Bank of Canada June 30, 2011 6.93M $360.24M
Iridian Asset Management June 30, 2011 5.69M $295.60M
Commerzbank Aktiengesellschaft Dec. 31, 2010 5.42M $153.32M
Osterweis Capital Management Dec. 31, 2010 4.82M $136.26M